Ibrutinib Combined with Venetoclax in Patients with Relapsed/Refractory Mantle Cell Lymphoma: Primary Analysis Results from the Randomized Phase 3 Sympatico Study
Titel:
Ibrutinib Combined with Venetoclax in Patients with Relapsed/Refractory Mantle Cell Lymphoma: Primary Analysis Results from the Randomized Phase 3 Sympatico Study
Auteur:
Wang, Michael Jurczak, Wojciech Trněný, Marek Belada, David Wrobel, Tomasz Ghosh, Nilanjan Keating, Mary-Margaret van Meerten, Tom Fernandez Alvarez, Ruben von Keudell, Gottfried Thieblemont, Catherine Peyrade, Frederic Andre, Marc Hoffmann, Marc Szafer Glusman, Edith Lin, Jennifer Dean, James P. Neuenburg, Jutta K. Tam, Constantine S.